DaShenLin Pharmaceutical Group Market Cap

DaShenLin Pharmaceutical Group has a market cap or net worth of 16.40 billion as of January 3, 2025. Its market cap has decreased by -43.40% in one year.

Market Cap

16.40B

Enterprise Value

19.25B

Revenue

26.54B

Ranking

n/a

PE Ratio

19.23

Stock Price

14.40

Market Cap Chart

Since July 31, 2017, DaShenLin Pharmaceutical Group's market cap has increased from 14.24B to 16.40B, an increase of 15.16%. That is a compound annual growth rate of 1.92%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	16.40B	-4.38%
Dec 31, 2024	17.15B	-39.52%
Dec 29, 2023	28.36B	-24.55%
Dec 30, 2022	37.59B	12.85%
Dec 31, 2021	33.31B	-35.46%
Dec 31, 2020	51.60B	89.92%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Mindray Bio-Medical Electronics	294.68B
Jiangsu Hengrui Medicine	285.82B
WuXi AppTec	152.01B
Zhangzhou Pientzehuang Pharmaceutical.,	126.13B
Aier Eye Hospital Group	116.12B
Shanghai United Imaging Healthcare	103.88B
Yunnan Baiyao Group Co.,Ltd	103.58B
Beijing Wantai Biological Pharmacy Enterprise	85.14B

Market Cap Rankings